Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corey C Foster

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Radiation Oncology (London, England)|November 27, 2014
Less advanced disease at initiation of salvage androgen deprivation therapy is associated with decreased mortality following biochemical failure post-salvage radiation therapyCorey C Foster, William C Jackson, Benjamin C Foster, et al.
Lung Cancer (Amsterdam, Netherlands)|March 20, 2019
Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall: A National Cancer Database AnalysisCorey C Foster, Chad G Rusthoven, David J Sher, et al.
Lung Cancer (Amsterdam, Netherlands)|April 30, 2019
Corrigendum to "Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall survival: A National Cancer Database Analysis" [Lung Cancer, Volume 130 (April) (2019) 162-168]Corey C Foster, Chad G Rusthoven, David J Sher, et al.
Radiation Oncology (London, England)|January 30, 2019
Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysisCorey C Foster, David J Sher, Chad G Rusthoven, et al.
Seminars in Radiation Oncology|June 7, 2020
Is It Worth It? Consequences of Definitive Head and Neck ReirradiationCorey C Foster, Ming Fan, Nancy Y Lee, et al.
Plos One|March 10, 2018
Treatment outcomes and HPV characteristics for an institutional cohort of patients with anal cancer receiving concurrent chemotherapy and intensity-modulated radiation therapyCorey C Foster, Andrew Y Lee, Larissa V Furtado, et al.
Plos One|July 6, 2018
Correction: Treatment outcomes and HPV characteristics for an institutional cohort of patients with anal cancer receiving concurrent chemotherapy and intensity-modulated radiation therapyCorey C Foster, Andrew Y Lee, Larissa V Furtado, et al.
Cancer|September 21, 2021
Immune-related adverse events are associated with improved response, progression-free survival, and overall survival for patients with head and neck cancer receiving immune checkpoint inhibitorsCorey C Foster, Marcus A Couey, Sara E Kochanny, et al.
International Journal of Radiation Oncology, Biology, Physics|April 21, 2020
Dose and Volume De-Escalation for Human Papillomavirus-Positive Oropharyngeal Cancer is Associated with Favorable Posttreatment Functional OutcomesCorey C Foster, Tanguy Y Seiwert, Ellen MacCracken, et al.
Oral Oncology|May 1, 2018
Definitive chemoradiation for locally-advanced oral cavity cancer: A 20-year experienceCorey C Foster, James M Melotek, Ryan J Brisson, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Radiation Oncology (London, England)|November 27, 2014
Less advanced disease at initiation of salvage androgen deprivation therapy is associated with decreased mortality following biochemical failure post-salvage radiation therapyCorey C Foster, William C Jackson, Benjamin C Foster, et al.
Lung Cancer (Amsterdam, Netherlands)|March 20, 2019
Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall: A National Cancer Database AnalysisCorey C Foster, Chad G Rusthoven, David J Sher, et al.
Lung Cancer (Amsterdam, Netherlands)|April 30, 2019
Corrigendum to "Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall survival: A National Cancer Database Analysis" [Lung Cancer, Volume 130 (April) (2019) 162-168]Corey C Foster, Chad G Rusthoven, David J Sher, et al.
Radiation Oncology (London, England)|January 30, 2019
Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysisCorey C Foster, David J Sher, Chad G Rusthoven, et al.
Seminars in Radiation Oncology|June 7, 2020
Is It Worth It? Consequences of Definitive Head and Neck ReirradiationCorey C Foster, Ming Fan, Nancy Y Lee, et al.
Plos One|March 10, 2018
Treatment outcomes and HPV characteristics for an institutional cohort of patients with anal cancer receiving concurrent chemotherapy and intensity-modulated radiation therapyCorey C Foster, Andrew Y Lee, Larissa V Furtado, et al.
Plos One|July 6, 2018
Correction: Treatment outcomes and HPV characteristics for an institutional cohort of patients with anal cancer receiving concurrent chemotherapy and intensity-modulated radiation therapyCorey C Foster, Andrew Y Lee, Larissa V Furtado, et al.
Cancer|September 21, 2021
Immune-related adverse events are associated with improved response, progression-free survival, and overall survival for patients with head and neck cancer receiving immune checkpoint inhibitorsCorey C Foster, Marcus A Couey, Sara E Kochanny, et al.
International Journal of Radiation Oncology, Biology, Physics|April 21, 2020
Dose and Volume De-Escalation for Human Papillomavirus-Positive Oropharyngeal Cancer is Associated with Favorable Posttreatment Functional OutcomesCorey C Foster, Tanguy Y Seiwert, Ellen MacCracken, et al.
Oral Oncology|May 1, 2018
Definitive chemoradiation for locally-advanced oral cavity cancer: A 20-year experienceCorey C Foster, James M Melotek, Ryan J Brisson, et al.
Pageof 3